The allowed application contains claims regarding the process of using microwave energy to accelerate two steps in performing all solid phase peptide synthesis, deprotection and coupling.
In addition the patent also covers the process of performing Fmoc and Boc chemistries, the two strategies employed in peptide synthesis.
CEM’s microwave peptide synthesis process also enables the production of longer, more difficult peptides that were not possible to produce using conventional techniques.
CEM Corporation president and CEO Michael Collins said that they are excited to see first claims accepted in Europe and are looking forward to the acceptance of additional patents filed in Europe and Asia.
“Microwave technology has seen wide acceptance in the scientific community since we first introduced microwave peptide synthesizers in 2003. Our Liberty Systems have become the best-selling automatic peptide synthesizers on the market and continue to be a powerful driver for growth for CEM,” Collins said.
